PubMed:26808467 / 141-282 JSONTXT

{"project":"c_corpus","denotations":[{"id":"T31","span":{"begin":13,"end":20},"obj":"6308"},{"id":"T32","span":{"begin":13,"end":20},"obj":"SO:0001437"},{"id":"T30","span":{"begin":13,"end":20},"obj":"CHEBI:15603"},{"id":"T33","span":{"begin":13,"end":20},"obj":"D007930"},{"id":"T34","span":{"begin":13,"end":20},"obj":"CHEBI:25017"},{"id":"T35","span":{"begin":13,"end":20},"obj":"D007930"},{"id":"T36","span":{"begin":26,"end":32},"obj":"SO:0001068"},{"id":"T37","span":{"begin":43,"end":48},"obj":"PR:Q5S006"},{"id":"T38","span":{"begin":43,"end":48},"obj":"PR:000003033"},{"id":"T39","span":{"begin":43,"end":48},"obj":"PR:Q5S007"},{"id":"T40","span":{"begin":80,"end":90},"obj":"D000067562"},{"id":"T41","span":{"begin":80,"end":90},"obj":"D000067562"},{"id":"T42","span":{"begin":91,"end":109},"obj":"C566739"},{"id":"T45","span":{"begin":118,"end":135},"obj":"D010300"},{"id":"T46","span":{"begin":118,"end":135},"obj":"D010300"}],"text":"Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common causes of late onset autosomal dominant form of Parkinson disease (PD)."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T1","span":{"begin":0,"end":141},"obj":"DRI_Approach"}],"text":"Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common causes of late onset autosomal dominant form of Parkinson disease (PD)."}